ALA arovella therapeutics limited
Add to My Watchlist 5.26% ! 9.0¢

At $23M market cap, around $6M of cash. Enterprise value would...

  1. Fc2020
    29 Posts.
    lightbulb Created with Sketch. 12
    clock Created with Sketch.
    25/10/21
    13:19
    Post #: 57047785
    At $23M market cap, around $6M of cash. Enterprise value would be around $17M. The main game is obviously INKT. However, Zolpimist might be enough to justify the value of the current Enterprise value. Has anyone seen or done any valuation on Zolpimist alone?
    ALA Price at posting: 4.7¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS ANSTO continuous piloting confirms exceptional rare earth recoveries
right-arrow Created with Sketch.
NEWS Listen: HotCopper Wire Podcast 025 – Locksley rap video gives Hilltop Hoods run for money
right-arrow Created with Sketch.
NEWS High-grade silver intercepts confirmed at Kempfield Project
right-arrow Created with Sketch.
NEWS Explore the latest ASX Market News
right-arrow Created with Sketch.
NEWS First assay results returned from ongoing drilling at Gold Duke Project
right-arrow Created with Sketch.
AII Becoming the largest conflict-free tungsten supplier in the world
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
9.0¢ 		Change
-0.005(5.26%) 		Mkt cap ! $107.7M
Open High Low Value Volume
9.5¢ 9.5¢ 9.0¢ $43.71K 473.1K

Buyers (Bids)

No. Vol. Price($)
1 13972 9.0¢
 

Sellers (Offers)

Price($) Vol. No.
9.1¢ 10000 1
View Market Depth
Last trade - 12.32pm 19/09/2025 (20 minute delay) ?
ALA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.